Drugs / TNhYP217 CAR T Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06885697 | Jul 2025 → Jun 2034 expected | colonic neoplasm, gastric neoplasm, lung neoplasm, mesothelioma +3 | National Cancer Institute (NCI) | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TNhYP217 CAR T Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06885697 ↗ |